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Using human sera monospecific for anti-Ro/SS-A an-
tibodies in an indirect immunofluorescence assay, Ro/ 
SS-A antigen was found to be present in nuclei of human 
fetal ectodermal cells and newborn epidermal keratin-
ocytes, but not in adult epidermal keratinocytes. Aft~r 
in vitro cultivation, Ro/SS-A antigen was also found m 
the nuclei of adult skin explant outgrowth cells. The 
localization of Ro/SS-A in fetal heart could not be pre-
cisely determined (possibly nuclear and membrane). Ex-
tracts from fetal skin and heart contained Ro/SS-A an-
tigen which is identical to the Ro/SS-A present in WiL2 
cell extract. The molecular weight of Ro/SS-A antigenic 
peptide present in these extracts is around 60K. 
Circulating anti-Ro/SS-A antibodies are present in patients 
with systemic lupus erythematosus (LE), subacute cutaneous 
LE, "ANA-negative" systemic LE, neonatal LE, congenital 
heart block, a nd Sjogren's syndrome [1-10]. Patients with 
neonatal LE, "ANA-negative" systemic LE, or subacute cuta-
neous LE who have these antibodies tend to have skin lesions 
limited predominantly to sun-exposed areas [2,3,7-9]. In neo-
natal LE patients t he presence of Ro/SS-A antibodies seems 
to correlate with t he development of the skin lesions and 
possibly t he heart lesions as well (6- 9]. These observations 
have stimulated us to examine t he distribution of Ro/SS-A 
antigen in human skin and heart tissue. Using anti-Ro/SS-A 
monospecific sera we have demonstrated that Ro/SS-A antigen 
is present in cell nuclei of newborn foreskin keratinocytes and 
feta l ectodermal cells, but not in adult human keratinocyte 
nuclei . Ro/SS-A antigen is also present in t he nuclei of t h e 
epidermal outgrowth cells of adult human sk in explants. The 
possible distribution of the Ro/SS-A antige n in h eart tissue 
was a lso examined. 
MATERIALS AND MATERIALS 
Sera 
Sera were obtained from patients with subacute cutaneous LE. Five 
sera were used in the study: three contained on ly anti -Ro/SS-A precip-
itin antibody based on immunodiffusion and counterimmunoelectro-
phoresis (#2216, #2243, #2369), one had only anti-Sm antibodies 
(#2063), while the other had anti-La/SS-B only {f/2081). The prototype 
sera used in the immunodiffusion analysis were obtained originally 
from Drs. Morris Reichlin and Eng Tan. The 3 anti -Ro/SS-A ant ibody 
containing sera were antinuclear antibody (ANA)-positive on human 
HEp-2 cells and WiL2 cells (1/80 to 1/160) but were negative on mouse 
kidney sections. The other 2 sera (anti-Sm and anti-La/SS-B) were 
ANA -positive on both human HEp-2 cells and mouse kidney sections. 
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The anti-La/SS-B antiserum {f/2081) had a HEp-2 ANA titer of 1/160. 
All 5 sera used were negative for antibodies against double-stranded 
DNA and histones, based on Crithidia.luciliae immunofluorescence and 
histone-reconstituted kidney immunof1uorescence. A normal human 
serum which was ANA-negative on human HEp-2 cells was used as 
control. 
Tissues 
Skin was obtained from normal adult females undergoing repeated 
cesarean section, normal nonpregnant adults, newborn males, and 
human fetuses of 12, 18, and 24 weeks' gestation. Heart t issue was also 
obtained from human fetuses of 12, 18, and 24 weeks' gestation. Surgical 
tissue was t ransported in steri le Hanks' balanced salt solution . The 
t issues were frozen in liquid nitrogen within 4 h after surgical excision 
or spontaneous abortions. The t issues were t hen cut in a cryostat at a 
t hickness of 4 pm. The sections were fixed in acetone at room temper-
ature for 10 min and kept at -7o·c. Sections were used within 2 weeks 
of preparation. 
Preparation of Cellular Extract for Immunodiffusion and Immunoblot 
Analyses 
WiL2 cell extract, as described earlier [11], was used in t he routine 
precipitin antibody immunodiffusion analysis. Extracts from fetal heart 
and skin were prepared in the following manner. Fetal hearts were first 
weighed. An equal volume of phosphate-buffered saline (PBS) was 
added and t he tissue was then homogenized in a blender. Skin was 
soaked in 0.25% trypsin at 37•c for 30 min following which the dermis 
was removed and discarded. The epidermis was minced into small 
pieces and homogenized in an equal volume of PBS using a t issue 
blender. The homogenized heart and skin preparations were centrifuged 
at 10,000 rpm at 4•c for 30 min. The supernatant containing the t issue 
extract was then subjected to immunodiffusion and immunoblot 
analyses. 
Indirect I m.mu.nofluorescence 
Sera were diluted with PBS initially 1/10 and t hen serially to 1/80. 
The reason we chose a dilution of 1/80 was based on t he original 
observation that serum #2081 gave positive staining t ite rs of 1/80 on 
normal adult skin, but sera #2216, #2243, and #2369 gave negative 
staining results. The serum dilutions were added onto the slides (human 
skin sections, fetal skin and heart sections, HEp-2 cells, WiL2 cells, 
and human fibroblast cytospin smears) and incubated at room temper-
atu re for 30 min. After washing in PBS twice for 10 min, fluorescein 
isothiocyanate (FITC)-Iabeled goat and antihuman gamma-globulin 
antiserum was added and incubated fo r another 30 min. After a second 
incubation, the slides were washed in PBS twice and then mounted in 
buffered glycerine conta ining 0.1% p-phenylene diamine and examined 
under an Ortholux fluorescence microscope (E. Leitz, Inc., Rockleigh, 
New Jersey) equipped for epi-illumination with an HBO 100 high-
pressure mercury lamp and K490 and K510 filters. The FITC-labeled 
goat antiserum used had the following characteristics: protein concen-
t ration of 10 mg/ml and the optimal conjugate dilution of 1/20 based 
on chess board titrations, FITC concentration of 56 11m/mi. 
Double lm.munodiffw;ion and Coun.terimm.unoelectrophoresis 
Double immunodiffus ion was carried out in a petri dish containing 
0.5% agarose in PBS. The protein concent ration of t he cellular extract 
was adjusted to 15 mg/ml. Counterimmunoelectrophoresis was per-
formed on 1% agarose in barbital buffer pH 8.0 using a cellular extract 
protein concentration of 5 mg/ml. 
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Immunoblot analysis 
Cellular extracts from WiL2 cells, human fetal skin and heart were 
subjected to 10% sodium dodecyl sulfate-polyacrylam ide gel electro-
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phoresis and then t ransferred onto nitrocellulose paper. After transfer, 
the paper was soaked in human serum dilu tions containing monospe· 
cific anti -Ro/88-A antibody. After incubation and washing, horse-
radish peroxidase-labeled goat antihuman lgG was added and incubated 
for at least 2 h. Thereafter, the paper was washed again and developed 
using Bio-Rad coloring reagent. The detailed method has been de-
scribed [1 2!. 
Cellular Antigen-Associated RNA Analysis 
Immunoprecipitation using the human antisera and 32P- labeled 
WiL2 cell extract as described before [12] was used to analyze the 
cellu lar antigen -associated RNA profile. The associated RNA profile 
was then used to verify the monospecificity of the human antisera. 
1 2 3 4 5 6 
FIG 1. RNA profiles precipitated by the anti-La/ 88-B, anti-8m, 
and anti-Ro/ 88-A containing sera used in this study. Lane 1: normal 
human serum control. Lane 2: 8m associated RNA profile (serum 
#2063) . Lane 3: La/ 88-B and Ro/ 88-A associated RNA profile (serum 
#2081). Lane~; 4- 6: Ro/ 88-A RNA pro!ile (sera #22 16, 2243, 2369). 
TABLE I. Reactivity of serum autoantibodies with different human 
substrates 
Adult skin 
Serum no. Specificity HEp-2 WiL2 Fibroblast 2 3 
Control 
2063 anti-8m +b + + + + + 
2081 anti-La/88-B + + + + + + 
2216 anti-Ro/88-A + + + 
2243 ant i-Ro/ 88-A + + + 
2369 anti -Ro/88-A + + + 
a Negative staining based on serum dilu tion 1/ 10. 
b Positive nuclear sta ining wi th serum dilution of 1/80. 
Skin. Explant Organ Culture 
The method that has been described earlier [ 13] was adapted for 
these studies. Four to ten days after cul ture, pieces of adul t skin 
explants were removed and frozen immediately with liquid ni trogen in 
OTC embedding media. Frozen sections were prepared and fixed in 
acetone at room temperature for 10 min . The cellular outgrowths of 
the skin explants were also fixed in acetone for 10 min . The outgrowth 
and frozen sections were then examined by indirect immunofluores-
cence using monospecific anti-Ro/ 88-A human antisera to identify the 
expression of Ro/ 88-A cellular antigen. 
Preparation of Specific Anti-Ro/SS-A Antibodies 
The method described earlier by Harmon et al [1 4] was followed and 
the purified antibodies obtained were used to stain the HEp-2 cells to 
verify the staining by the monospecific human antiserum. 
RESULTS 
Based on double immunodiffusion and counterimmunoelec-
trophoresis analysis using WiL2 cell extract as the antigenic 
material, sera #2216, #2243, and #2369 were monospecific for 
anti-Ro/SS-A precipitin autoantibodies, while serum #2063 and 
serum #2081 were monospecific for anti-Sm and anti-La/SS-B 
antibodies, respectively. The monospecificity of those sera con-
taining anti-Ro/SS-A and anti-Sm was further substantiated 
by determining the cellular antigen-associated RNA profiles as 
shown in Fig 1. No specific RNA could be precipitated by 
normal human serum (lane 1). Anti-Sm was capable of precip-
itating at least two prominent RNAs, which were similar to 
that described by Lerner et a! as U1 and U2 RNAs (lane 2). 
La/SS-B was associated with several RNAs including Epstein-
Barr virus-associated RNAs (EBER) (lane 3, top 2 bands) and 
other RNAs. The 3 sera containing monospecific anti-Ro/ SS-
A antibodies precipitated RNAs of similar profile as shown in 
lanes 4- 6. This suggested that these 3 sera did not contain 
other precipitin antibodies such as anti-nRNP, anti-Sm, or 
anti-La/SS-B. These 3 sera were then used to stain various 
substrates including human adult skin, newborn foreskin, hu -
man fetal skin, human feta l heart, and adult huma n skin 
explants, to determine the distribut ion of the Ro/ SS-A antige n 
in these tissues. Furthermore, specific anti-Ro/ SS-A antibodies 
were purified from serum #2243 to stain HEp-2 cell smears to 
verify the staining pattern observed. 
The reactivity of the sera on the different substrates is 
summarized in Table I and Table II. Normal human serum did 
not stain any substrate used. Positive control sera for anti -Sm 
(#2063) and anti-La/SS-B (#2081) did stain a ll substrates, 
giving a speckled nuclear staining pattern. Serum #2081 gave 
staining titers of 1/80 on normal human adult skin, as shown 
in Fig 2a, but the 3 anti-Ro/SS-A sera did not (Fig 2b) . As 
shown in Table I, anti-Ro/SS-A containing monospecific sera 
stained HEp-2 cells (Fig 3a), human fibroblas t (Fig 3b), human 
spleen imprints (Fig 3c), and WiL2 cells, and all gave speckled 
or particulate nuclear staining patterns. The monospecific anti -
Ro/SS-A antiserum did not stain norma l skin from either 
pregnant or nonpregnant adult humans. 
Human skin explants were prepared and incubated in vitro 
TABLE IJ. Reactivity of serum autoantibodies with newborn and fetal human. tissue 
Newborn foreskin 
Serum no. Specificity 
Control 
2063 anti-8m 4+h 
2081 anti-La/ 88-13 4+ 
2216 anti-Ro/88-A 2+< 
2243 anti-Ro/88-A 
2369 anti-Ro/88-A 
a Negative nuclear staining wi th serum dilution l / 10. 
b Positive nuclear staining with serum dilu tion 1/80. 
c Positive nuclea r staining with serum dilut ion l /20. 
d Positive nuclear staining with serum dilution 1/ 40. 
2 3 
4+ 4+ 
4+ 4+ 
2+ 3+d 
2+ 3+ 
12 wk 
4+ 
4+ 
4+ 
3+ 
3+ 
Fetal skin Fetal heart 
18 wk 24 wk 12 wk 18 wk 24 wk 
4+ 4+ 4+ 4+ 4+ 
4+ 4+ 4+ 4+ 4+ 
4+ 4+ 3+ 4+ 3+ 
3+ 4+ 3+ 3+ 3+ 
3+ 3+ 2+ 2+ 2+ 
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FIG 2. Fluoromicrograph of anti-La/SS-B and anti-Ro/SS-A staining on normal adu lt human skin sections. a, Epidermal nuclear staining by 
serum //2081 (see small arrowhead). Large arrowheads indicate the dermal-epidermal junction. b, Absence of epiderma l nuclear staining by serum 
//2369 (see small arrowhead). Large arrowheads indicate dermal-epidermal junction. 
FIG 3. Fluoromicrograph of anti-Ro/SS-A sta ining by se rum #2216 
on different substrates: HEp-2 cells (a), huma n skin fibroblast cytospi n 
smear (b), huma n spleen imprint smear (c) , 20-week gestation fetal 
skin section (d) (small a.rrowhead demonstrates pa rticulate epidermal 
nuclear sta ining and large arrowheads indicate dermal-epidermal junc-
ti on) . 
at 37•c in a C02 incubator for several days. Starting 4 days 
after initiation of culture the explants were removed every 2 
days. Frozen sections were prepared and used as indirect im-
munofluorescence substrates. The monospecific anti-Ro/SS-A 
antiserum gave speckled or particulate nuclear staining pat-
terns on these substrates as shown in Fig 4a in cells located in 
the lower epidermis and upper dermis. In addition, the anti-
serum also stained the outgrowth cells as shown in Fig 4b, 
giving a particulate nuclear staining pattern. 
Frozen sections were prepared from newborn foreskin, fetal 
skin, and fetal heart and then used for anti-Ro/SS-A staining. 
The results were shown in Table II. All 3 anti-RojSS-A sera 
reacted with fetal skin and heart while 2 reacted with foreskin. 
Serum #2369 did not stain the newborn foreskin sections. The 
staining patterns on these different substrates were similar, 
except for the one seen with heart sections (Fig 4c). Generally, 
they gave speckled or particulate nuclear staining as shown in 
Fig 3d on fetal skin sections. The staining on fetal heart 
sections as seen in Fig 4c, appeared to be particulate, but the 
exact localization was not clear and needed further evaluation. 
To do this we used a preparation of purified anti-Ro/SS-A 
antibodies obtained from precipitin lines. The purified anti-
Ro/SS-A antibodies produced the same pattern that was pro-
duced by the monospecific anti-Ro/SS-A antisera. The purified 
anti-Ro/SS-A antibodies from another monospecific serum also 
gave particulate nuclear staining on human spleen imprint 
smears (data not shown). Thomas K. Burnham has identified 
this pattern as the large speckled-like thread pattern that he 
has described earlier (personal communication) . 
The soluble cellular extract was prepared from fetal skin and 
heart and then used in the immunodiffusion analysis against 
monospecific anti-Ro/SS-A sera. As shown in Fig 5, there are 
single precipitation lines between the monospecific anti-Ro/ 
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F IG 4 . Fluoromicrograph of anti-Ro/SS-A staining by serum #2216 
on different substrates: frozen section of 6-clay-old sk in explant (a), 
outgrowth cells of 6-day-old skin explant (b) , froze r~ section ?f 20-week 
feta l heart (c), sta ini ng on HE(J-2 cells by punfied antr-Ro/SS-A 
antibodies (d). 
F IG 5. Immunodiffusion analysis for the presence of Ro/SS-A an-
t iaen in fetal skin and heart extract. Center well: monospecific anti-
R~/SS-A serum. Wells I and 4: WiL2 cell extract. Well 2: feta l skin 
extract. Well 3: feta l heart extract. 
SS-A serum dilu tion and the heart and skin extracts. Note also 
t hat t hese lines are identical. This confirms that Ro/SS-A is 
present in human feta l heart and skin. This is further substan-
t iated by the result of the immunoblot analysis shown in Fig 6. 
One peptide of M, 60,000 from Wi12 extract (lane 2) , heart 
extract (la ne 3), and skin extract (lane 4) was recognized by 
the monospecific anti -Ro/SS-A ant iserum. 
DISCUSSION 
Anti-Ro/SS-A ant ibodies are present in patients wit h sys-
temic LE, neonata l LE, subacute cutaneous LE, Sjogren's syn-
drome, and congeni tal heart block. It has been suggested t hat 
the presence of t his antibody is directly related to the devel-
opment of skin a nd heart lesions in patients with neonatal LE 
and congenita l heart block [6- 9]. The distribution of the Ro/ 
92 K L 
66K 
45K 
31K 
21.5K 
14.5 K 
1 2 3 4 
FIG 6. lmmunoblot analysis of antigens from WiL2 cell extract 
(lane 2), human 20-week feta l heart extract (lane 3), and 20-week fetal 
skin extract (lane 4) with anti-Ro/SS-A monospecific antiserum. Lane 
I contains the molecular weight standards indicated at the left. 
SS-A ant igen wit hin t he cell and in various t issues is contro-
versial. However, recent data have suggested t hat it might be 
present in the nucleus during some parts of t he cell cycle [14]. 
Since t he pathology of neonatal LE skin lesions is focused at 
t he dermal-epidermal junction and t hat of congenital heart 
block is focused within t he cardiac conducting system, it is 
reasonable to suspect t he presence of the Ro/SS-A antigen in 
those tissues. Using the monospecific anti-Ro/SS-A antisera, 
we have demonstrated t hat Ro/SS-A antigen is present at least 
in t he nuclei of human fetal skin, newborn foreskin, adult skin 
explant, and adul t skin outgrowth cells. Under indirect immu-
nofluorescence the antibody gave a particulate pattern of nu-
clear staining which was similar to the large speckled-like 
thread pattern t hat has been described earlier by Burnham on 
human spleen imprints [15]. The amount of the Ro/SS-A 
antigen in adul t human skin, newborn skin, and fetal skin 
seems to be variable. There was no detectable Ro/SS-A antigen 
in adul t human skin using 3 different monospecific anti-Ro/ 
SS-A antisera. However, it became detectable when the skin 
fragments were maintained in vitro at 37oC for several days. 
This suggests t hat originally, there is only a minute amount of 
Ro/SS-A in t he skin . Once the skin is cul tured in vitro, t he 
metabolism of t he cells is activated and more cellular proteins 
including Ro/SS-A antigen are synthesized. T his also indirectly 
suggests t hat t he amount of Ro/SS-A in individual tissues is 
more or less related to t he proliferative status or the metabolic 
stage. The higher metabolic activity, t he more Ro/SS-A in a 
particular stage. This might explain t he variable staining of 
human spleen cells by anti-Ro/SS-A antiserum, as seen in 
Fig 3c. 
Previously, it had been suggested t hat Ro/SS-A antigen was 
present in neonatal skin , but not in 16- to 18-week fetal skin 
[16]. Based on the data generated in the present study, we 
believe Ro/SS-A is present in the skin or ectoderm during the 
early feta l stage, and t hat t he relative concentration of Ro/SS-
A in skin decreases as the skin matures, with Ro/SS-A being 
either absent from adult human skin or present at levels which 
are not detectible by an immunofluorescence technique. 
Whether t he antigen is expressed in t he cytoplasm or cell 
membrane as has been suggested by others, remains to be 
further explored. It has been suggested that Ro/SS-A is present 
in the cell membrane of cul tured keratinocytes after UV irra-
diation [16]. 
T he location of Ro/SS-A antigen in heart tissue is still 
unknown. As seen in Fig 4c, there was particulate staining, 
possibly on the cell membrane and nucleus. It is difficult to get 
good-quali ty sections from feta l heart. We are also not sure 
that t he distribution of t he Ro/SS-A antigen includes the 
conducting system of heart. Currently efforts are being made 
to address this question. 
The antigenic peptide for Ro/SS-A is a peptide of M, 60,000 
which is present in extracts from Wi12 cells, feta l skin, and 
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heart tissue. This suggests that there is no difference between 
Ro/SS-A ant igenic particles from different tissues. The only 
difference is probably in the amount present in different tissues. 
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